Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria by Ciron, J., Gueguen, A., Al Khedr, A., Bourre, B., Clavelou, P., Defer, G., Durand-Dubief, F., Labauge, P., Ouallet, J.-C., Pittion Vouyovitch, S., Tourbah, A., Vermersch, P.

Get full text

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label... by Kapoor, Raju, Chang, Ih, Deykin, Aaron, Forrestal, Fiona, Lucas, Nisha, Yu, Bei, Arnold, Douglas L, Freedman, Mark S, Hartung, Hans-Peter, Jeffery, Douglas, Sellebjerg, Finn, Cadavid, Diego, Mikol, Dan, Bartholomé, Emmanuel, D'Hooghe, Marie, Devonshire, Virginia, Grand'Maison, François, Jacques, François, Lapierre, Yves, Morrow, Sarah, Stetkarova, Ivana, Talabova, Marika, Frederiksen, Jette, Kant, Matthias, Petersen, Thor, Eralinna, Juha-Pekka, Brassat, David, Brochet, Bruno, Vermersch, Patrick, Vukusi, Sandra, Baum, Karl, Maeurer, Mathias, Meuth, Sven, Hardiman, Orla, Achiron, Anat, Karussis, Dimitrios, Bergamaschi, Roberto, Grimaldi, Luigi, Salvetti, Marco, Scarpini, Elio, Sola, Patrizia, Zaffaroni, Mauro, Frequin, Stephan, Hupperts, Raymond, Killestein, Joep, Schrijver, Hans, van Munster, Erik, Drozdowski, Wieslaw, Fryze, Waldemar, Klodowska-Duda, Gabriela, Motta, Ewa, Podemski, Ryszard, Selmaj, Krzysztof, Stepien, Adam, Tutaj, Andrzej, Boyko, Alexey, Escartin, Antonio, Garcia-Merino, Antonio, Hernandez Perez, Miguel Angel, Ayuso, Guillermo Izquierdo, Lallana, José Meca, Gairin, Xavier Montalban, Gunnarsson, Martin, Roshanisefat, Homayoun, Sundstrom, Peter, Gran, Bruno, Kapoor, Raju, Mattison, Paul, Pearson, Owen, Rashid, Waqar, Rog, David, Silber, Eli, Bandari, Daniel, Camac, Ann, Cohan, Stanley, Fabian, Michelle, Florin, Jack, Freedman, Steven, Garwacki, Dennis, Goldman, Myla, Harrison, Daniel, Herrman, Craig, Huang, Deren, Jeffery, Douglas, Kamin, Stephen, Langer-Gould, Annette, Mattson, David, Miller, Tamara, Moses, Harold, Muley, Suraj, Nielsen, Allen, Pardo, Gabriel, Picone, MaryAnn, Robertson, Derrick, Sheppard, Christopher, Thrower, Ben, Twyman, Cary, Waubant, Emmanuelle, Yadav, Vijayshree, Zabad, Rana

Get full text

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial by Cadavid, Diego, Mellion, Michelle, Hupperts, Raymond, Edwards, Keith R, Calabresi, Peter A, Drulović, Jelena, Giovannoni, Gavin, Hartung, Hans-Peter, Arnold, Douglas L, Fisher, Elizabeth, Rudick, Richard, Mi, Sha, Chai, Yi, Li, Jie, Zhang, Yiwei, Cheng, Wenting, Xu, Lei, Zhu, Bing, Green, Susan M, Chang, Ih, Deykin, Aaron, Sheikh, Sarah I, Agüera Morales, Eduardo, Al Khedr, Abdullatif, Ampapa, Radek, Arroyo, Rafael, Belkin, Martin, Bonek, Robert, Boyko, Alexey, Capra, Ruggero, Centonze, Diego, Clavelou, Pierre, Debouverie, Marc, Drulovic, Jelena, Edwards, Keith, Evangelou, Nikos, Evdoshenko, Evgeniy, Fernández, Oscar, Fernández Sánchez, Victoria, Freedman, Mark, Freedman, Steven, Fryze, Waldemar, Garcia-Merino, Antonio, Gavric-Kezic, Mira, Ghezzi, Angel, Gout, Olivier, Grimaldi, Luigi, Hertmanowska, Hanka, Hintzen, Rogier, Hradilek, Pavel, Hupperts, Raymond, Ilkowski, Jan, Ivashinenkova, Evelina, Izquierdo, Guillermo, Jacques, Francois, Jakab, Gabor, Khabirov, Farit, Klodowska-Duda, Gabriela, Komoly, Samuel, Kostic, Smiljana, Kovarova, Ivana, Kremenchuzky, Marcelo, Laganke, Christopher, LaPierre, Yves, Maciejowski, Maciej, Maison, Francois Grand, Marfia, Girolama Alessandra, Martínez Yélamos, Sergio, Meluzinova, Eva, Montalban, Xavier, Murray, Ronald, Naismith, Robert, Newsome, Scott, Nguyen, Viet, Oreja, Delia, Pardo, Gabriel, Pasechnik, Elena, Patti, Francesco, Potemkowski, Andrzej, Prokopenko, Semen, Qian, Peiqing, Rodríguez-Antigüedad, Alfredo, Rossman, Howard, Rozsa, Csilla, Sánchez López, Fernando, Selmaj, Krzysztof, Silber, Eli, Stepien, Adam, Stepniewska, Anna, Swiat, Maciej, Toncev, Gordana, Tourbah, Ayman, Trushnikova, Tatyana, Uccelli, Antonio, Vachova, Marta, Valis, Martin, Vecsei, Laszlo, Wiertlewski, Sandrine, Zaffaroni, Mauro, Zielinski, Tomasz

Get full text

Lipid lowering agents are associated with a slower cognitive decline in Alzheimer’s disease by Masse, I, Bordet, R, Deplanque, D, Al Khedr, A, Richard, F, Libersa, C, Pasquier, F

Get full text

Delay from treatment start to full effect of immunotherapies for multiple sclerosis by Roos, Izanne, Leray, Emmanuelle, Frascoli, Federico, Casey, Romain, Brown, J William L, Horakova, Dana, Havrdova, Eva K, Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Sá, Maria José, Cartechini, Elisabetta, Boz, Cavit, Granella, Franco, Hupperts, Raymond, Terzi, Murat, Lechner-Scott, Jeannette, Spitaleri, Daniele, Van Pesch, Vincent, Soysal, Aysun, Olascoaga, Javier, Prevost, Julie, Aguera-Morales, Eduardo, Slee, Mark, Csepany, Tunde, Turkoglu, Recai, Sidhom, Youssef, Gouider, Riadh, Van Wijmeersch, Bart, McCombe, Pamela, Macdonell, Richard, Coles, Alasdair, Malpas, Charles B, Butzkueven, Helmut, Vukusic, Sandra, Kalincik, Tomas

Get full text

Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease by Devos, David

Get full text

New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions by Brisset, Jean-Christophe, Kremer, Stephane, Hannoun, Salem, Bonneville, Fabrice, Durand-Dubief, Francoise, Tourdias, Thomas, Barillot, Christian, Guttmann, Charles, Vukusic, Sandra, Dousset, Vincent, Cotton, Francois, Ameli, R., Anxionnat, R., Audoin, B., Attye, A., Bannier, E., Barillot, C., Ben Salem, D., Boncoeur-Martel, M.-P., Bonhomme, G., Bonneville, F., Boutet, C., Brisset, J.C., Cervenanski, F., Claise, B., Commowick, O., Constans, J.-M., Cotton, F., Dardel, P., Desal, H., Dousset, V., Durand-Dubief, F., Ferre, J.-C., Gaultier, A., Gerardin, E., Glattard, T., Grand, S., Grenier, T., Guillevin, R., Guttmann, C., Krainik, A., Kremer, S., Lion, S., Champfleur, N. Menjot De, Mondot, L., Outteryck, O., Pyatigorskaya, N., Pruvo, J.-P., Rabaste, S., Ranjeva, J.-P., Roch, J.-A., Sadik, J.-C., Sappey-Marinier, D., Savatovsky, J., Stankoff, B., Tanguy, J.-Y., Tourbah, A., Tourdias, T., Brochet, B., Casey, R., Cotton, F., De Sèze, J., Douek, P., Guillemin, F., Laplaud, D., Lebrun-Frenay, C., Mansuy, L., Moreau, T., Olaiz, J., Pelletier, J., Rigaud-Bully, C., Stankoff, B., Vukusic, S., Debouverie, M., Edan, G., Ciron, J., Lubetzki, C., Vermersch, P., Labauge, P., Defer, G., Berger, E., Clavelou, P., Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Créange, A., Camdessanché, J.-P., Bakchine, S., Maurousset, A., Patry, I., De Broucker, T., Pottier, C., Neau, J.-P., Labeyrie, C., Nifle, C.

Get full text

Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France by Lebrun-Frenay, Christine, Moulignier, Antoine, Pierrot-Deseilligny, Charles, Benrabah, Rabah, Moreau, Thibault, Lubetzki, Catherine, Monchecourt, Françoise

Get full text

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system by Sabathé, Camille, Casey, Romain, Vukusic, Sandra, Leray, Emmanuelle, Mathey, Guillaume, De Sèze, Jérôme, Ciron, Jonathan, Wiertlewski, Sandrine, Ruet, Aurélie, Pelletier, Jean, Zéphir, Hélène, Michel, Laure, Lebrun-Frenay, Christine, Moisset, Xavier, Thouvenot, Eric, Camdessanché, Jean-Philippe, Bakchine, Serge, Stankoff, Bruno, Al Khedr, Abdullatif, Cabre, Philippe, Maillart, Elisabeth, Berger, Eric, Heinzlef, Olivier, Hankiewicz, Karolina, Moreau, Thibault, Gout, Olivier, Bourre, Bertrand, Wahab, Abir, Labauge, Pierre, Montcuquet, Alexis, Defer, Gilles, Maurousset, Aude, Maubeuge, Nicolas, Dimitri Boulos, Dalia, Ben Nasr, Haïfa, Nifle, Chantal, Casez, Olivier, Laplaud, David-Axel, Foucher, Yohann

Get full text

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study by Papeix, Caroline, Castelnovo, Giovanni, Leray, Emmanuelle, Coustans, Marc, Levy, Pierre, Visy, Jean-Marc, Kobelt, Gisela, Lamy, Fabienne, Allaf, Bashar, Heintzmann, François, Chouette, Isabelle, Raponi, Eric, Durand, Barbara, Grevat, Emmanuelle, Kamar, Driss, Debouverie, Marc, Lebrun-Frenay, Christine

Get full text

Nosology and etiologies of acute longitudinally extensive transverse myelitis by Collongues, N, Papeix, C, Zéphir, H, Audoin, B, Cotton, F, Durand-Dubief, F, Vukusic, S, Brassat, D, Laplaud, D, Marignier, R

Get full text

Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI by Roca, P., Attye, A., Colas, L., Tucholka, A., Rubini, P., Cackowski, S., Ding, J., Budzik, J.-F., Renard, F., Doyle, S., Barbier, E.L., Casey, R., Vukusic, S., Lassau, N., Verclytte, S., Cotton, F., Brochet, B., Casey, R., Cotton, F., De Sèze, J., Douek, P., Guillemin, F., Laplaud, D., Lebrun-Frenay, C., Mansuy, L., Moreau, T., Olaiz, J., Pelletier, J., Rigaud-Bully, C., Stankoff, B., Vukusic, S., Marignier, R., Debouverie, M., Ciron, J., Ruet, A., Collongues, N., Lubetzki, C., Vermersch, P., Labauge, P., Defer, G., Cohen, M., Fromont, A., Wiertlewsky, S., Berger, E., Clavelou, P., Audoin, B., Giannesini, C., Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Faure, J., Maurousset, A., Patry, I., Pottier, C., Maubeuge, N., Labeyrie, C., Nifle, C., Anxionnat, R., Attye, A., Bannier, E., Barillot, C., Ben Salem, D., Boncoeur-Martel, M.-P., Bonneville, F., Boutet, C., Brisset, J.-C., Cervenanski, F., Claise, B., Commowick, O., Constans, J.-M., Dardel, P., Desal, H., Durand-Dubief, F., Ferre, J.-C., Gerardin, E., Glattard, T., Grenier, T., Guillevin, R., Guttmann, C., Krainik, A., Kremer, S., Lion, S., Menjot de Champfleur, N., Outteryck, O., Pyatigorskaya, N., Pruvo, J.-P., Rabaste, S., Ranjeva, J.-P., Roch, J.-A., Sadik, J.C., Sappey-Marinier, D., Savatovsky, J., Tanguy, J.-Y., Tourbah, A., Tourdias, T.

Get full text

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study by Calabresi, Peter A, Kieseier, Bernd C, Arnold, Douglas L, Balcer, Laura J, Boyko, Alexey, Pelletier, Jean, Liu, Shifang, Zhu, Ying, Seddighzadeh, Ali, Hung, Serena, Deykin, Aaron

Get full text

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis by Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E

Get full text

Methylprednisolone-induced immune thrombocytopenia by Royer, Bruno, Lee, Ketty, Gruson, Berengere, Roszkiewicz, France, Al Khedr, Abdullatif, Colson, Agnes, Camboulives, Agnes, Bierling, Philippe, Marolleau, Jean Pierre

Get full text

Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study by Laplaud, D. A., Barbin, L., Rousseau, Chloé, Jousset, N., Casey, Romain, Debouverie, Marc, Vukusic, S., de Seze, J., Brassat, D., Wiertlewski, S., Brochet, Bruno, Pelletier, Jean, Vermersch, Patrick, Edan, Gilles, Lebrun-Frenay, Christine, Clavelou, Pierre, Thouvenot, Eric, Camdessanche, J. -P., Tourbah, Ayman, Stankoff, Bruno, Al Khedr, A., Cabre, Philippe, Papeix, C., Berger, Eric, Heinzlef, Olivier, Debroucker, T., Moreau, Thibault, Gout, O., Bourre, Bertrand, Creange, A., Labauge, Pierre, Magy, L., Defer, Gilles, Foucher, Y.

Get full text

Myélopathies infectieuses : profils cliniques, paracliniques et évolutifs by Ramirez, C., de Seze, J., Delalande, S., Michelin, E., Ferriby, D., Al Khedr, A., Stojkovic, T., Destée, A., Vermersch, P.

Get full text

Infectious myelopathies: clinical, serological, and prognostic patterns by Ramirez, C, de Seze, J, Delalande, S, Michelin, E, Ferriby, D, Al Khedr, A, Stojkovic, T, Destée, A, Vermersch, P

Get full text

C7-1 Fonctions exécutives et syndromes démentiels by Godefroy, O., Roussel-Pieronne, M., Routier, A., Tourbier, V., Dupuy-Sonntag, D., Al Khedr, A., Périn, B.

Get full text

P2-20 Comparaison de la tolérance et de l’efficacité à 2 ans des inhibiteurs de l’acétylcholinestérase (IAChE) chez des patients atteints de maladie d’alzheimer by Paulin, M., Seillier, D., Husson, J., Al khedr, A., Memin, A., Lebert, F., Bombois, S., Mackowiak-Cordoliani, M.A., Pasquier, F.

Get full text